BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37884781)

  • 1. Design anticancer potential of Zn(II)isoleucinedithiocarbamate complex on MCF-7 cell lines: synthesis, characterization, molecular docking, molecular dynamic, ADMET, and in-vitro studies.
    Irfandi R; Raya I; Ahmad A; Fudholi A; Riswandi ; Santi S; Azalea WP; Putri SE; Alam MN; Supratman U; Olubode SO; Abdalrazaq EA; Kandeel M; Soekamto NH; Natsir H; Maming ; Ramlawati
    Mol Divers; 2023 Oct; ():. PubMed ID: 37884781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Complex Design of Fe (II) Isoleucine Dithiocarbamate as a Novel Anticancer and Antivirus against SARSCOV-2 (COVID-19).
    Irfandi R; Riswandi R; Raya I; Ahmad A; Fudholi A; Jarre S; Tirto Sari DR; Santi S; Wijaya RI; Prihantono P
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3113-3123. PubMed ID: 36172674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of Ni(II)Cysteine-Tyrosine Dithiocarbamate Complex: Synthesis, Characterization, Molecular Docking, Molecular Dynamic, and Anticancer Activity on MCF-7 Breast Cancer Cell Line.
    Pratiwi E; Raya I; Natsir H; Irfandi R; Taba P; Arfah R; Rasyid H; Hala Y; Kasim S; Khaerunnisa AB; Ilham B; Mazaya M; Tanzil Y; Luthfiana D
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1301-1313. PubMed ID: 38679991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer potential of Cu(II)prolinedithiocarbamate complex: design, synthesis, spectroscopy, molecular docking, molecular dynamic, ADMET, and in-vitro studies.
    Irfandi R; Raya I; Ahmad A; Fudholi A; Santi S; Puspa Azalea W; Ratih Tirto Sari D; Jarre S; Eka Putri S; Kartina D
    J Biomol Struct Dyn; 2023; 41(22):12938-12950. PubMed ID: 36690606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential anticancer activity of Mn (II) complexes containing arginine dithiocarbamate ligand on MCF-7 breast cancer cell lines.
    Prihantono ; Irfandi R; Raya I; Warsinggih
    Ann Med Surg (Lond); 2020 Dec; 60():396-402. PubMed ID: 33235715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, molecular docking studies of Mn(II)Prolinedithiocarbamate and its potential as anticancer agents.
    Jarre S; Raya I; Prihantono ; Santi S
    Mol Divers; 2024 Apr; 28(2):889-900. PubMed ID: 36913052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of Zn(II) arginine dithiocarbamate cytotoxicity in T47D breast cancer and fibroblast cells.
    Prihantono P; Irfandi R; Raya I
    Breast Dis; 2021; 40(S1):S55-S61. PubMed ID: 34057119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel imidazole-based azo molecule: synthesis, characterization, quantum chemical calculations, molecular docking, molecular dynamics simulations and ADMET properties.
    Karabacak Atay Ç; Dilek Ö; Tilki T; Dede B
    J Mol Model; 2023 Jul; 29(8):226. PubMed ID: 37405575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Complex of Zinc (II) Dichloroethylenediamine: Synthesis, Characterization, In-silico, and In-vitro Evaluation against Cervical Cancer Cells.
    Raya I; Kartina D; Wijaya RI; Irfandi R; Abdalrazaq EA; Prihantono P; Santi S; Pratiwi E; Khaerunnisa AB; Luthfiana D; Musa B; Natsir H; Maming M; Zainuddin ZD; Ramlawati R; Fudholi A; Usman AN; Supratman U; Mazaya M; Sufiandi S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4155-4165. PubMed ID: 38156851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
    Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
    J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel palladium(II) and Zinc(II) Schiff base complexes: Synthesis, biophysical studies, and anticancer activity investigation.
    Fahmy HM; Mosleh AM; El-Sayed AA; El-Sherif AA
    J Trace Elem Med Biol; 2023 Sep; 79():127236. PubMed ID: 37285632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed Ligand-metal Complexes of 2-(butan-2-ylidene) Hydrazinecarbothioamide- Synthesis, Characterization, Computer-Aided Drug Character Evaluation and in vitro Biological Activity Assessment.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Curr Comput Aided Drug Des; 2021; 17(1):107-122. PubMed ID: 31556860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes.
    Khan T; Dixit S; Ahmad R; Raza S; Azad I; Joshi S; Khan AR
    J Chem Biol; 2017 Jul; 10(3):91-104. PubMed ID: 28684996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent cyclometallated Pd(II) antitumor complexes bearing α-amino acids: synthesis, structural characterization, DNA/BSA binding, cytotoxicity and molecular dynamics simulation.
    Abedanzadeh S; Karami K; Rahimi M; Edalati M; Abedanzadeh M; Tamaddon AM; Jahromi MD; Amirghofran Z; Lipkowski J; Lyczko K
    Dalton Trans; 2020 Nov; 49(42):14891-14907. PubMed ID: 33075117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Bromo and methoxy substituted Schiff base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, and ADMET studies.
    Abdel-Rahman LH; Abdelghani AA; AlObaid AA; El-Ezz DA; Warad I; Shehata MR; Abdalla EM
    Sci Rep; 2023 Feb; 13(1):3199. PubMed ID: 36823294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucosamine conjugation to zinc(II) complexes of a bis-pyrazole ligand: syntheses, characterization and anticancer activity.
    Bhattacharyya S; Sarkar A; Dey SK; Mukherjee A
    J Inorg Biochem; 2014 Nov; 140():131-42. PubMed ID: 25113858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of Ni(II) and Zn(II) complexes of (furan-2-yl)methyl(2-(thiophen-2-yl)ethyl)dithiocarbamate (ftpedtc): X-ray structures of [Zn(ftpedtc)2(py)] and [Zn(ftpedtc)Cl(1,10-phen)].
    Jamuna Rani P; Thirumaran S; Ciattini S
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():1164-73. PubMed ID: 25305608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
    Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
    Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.